Status:
UNKNOWN
Pilot Study of Maintenance Therapy With Intravenous AMANTADINE
Lead Sponsor:
Rabin Medical Center
Conditions:
Parkinson Disease
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
This is a pilot study for Maintenance Intravenous Treatment with AMANTADINE in patient with PARKINSON'S Disease who are not well balanced with medical treatment.
Eligibility Criteria
Inclusion
- Patients with idiopathic Parkinson disease
- Age\<80
- Patients with no motor improvement under optimal treatment with anti parkinson medications
- Patients with moderate to severe dyskinesias
- Patients with PD with side effects who can not tolerate anti parkinson medications
Exclusion
- Age\>80
- Patients with Parkinson syndromes, vascular parkinsonism or drug-induced parkinsonism
- Patients with PD who developed adverse reactions to oral amantadine
- Contraindication of amantadine treatment
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01190553
Start Date
November 1 2010
End Date
June 1 2012
Last Update
October 13 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.